Skip to Main Content
Try STAT+ TODAY
Trending:
First Opinion
Biotech
Health
Coronavirus
The Readout

Moderna’s patent problems & clocking the CRISPR race

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan May 17, 2017

Reprints
The READOUT
Alex Hogan/STAT

The Readout for May 17, 2017

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana covers biotech and contributes to The Readout newsletter.

The health insurer will see you now: How UnitedHealth…
The health insurer will see you now: How UnitedHealth is keeping more profits, as your doctor
‘A constant information lag’: The troubled recall of Philips…
‘A constant information lag’: The troubled recall of Philips CPAP machines underscores flaws in device oversight
When women are denied an abortion, their children fare…
When women are denied an abortion, their children fare worse than peers
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories